Search
for
Sort by
Research 30 of 432
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- Paclitaxel/Platinum combination regimen and alopecia
- Toxic Effect of Platinum Compounds: Molecular Mechanisms of Toxicity
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Alopecia and Hair Damage Induced by Oncological Therapy
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- Evaluation of Short-Term Efficacy and Long-Term Oncologi-Cal Outcomes of Different Paclitaxels Plus Platinum Regi-Mens in the Treatment of Serous Ovarian Cancer—A Real World Study
- The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study
- Perspectives in Head and Neck Medical Oncology
- DRUGS AND DEVICES IN PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED ALOPECIA: WHEN AND HOW SHOULD BE EMPLOYED
- Dermatological adverse events with taxane chemotherapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Chemotherapy-Induced Alopecia
- Present Chemotherapy Induced Alopecia and Research in Future
- Use of chemotherapy during human pregnancy
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Mucocutaneous reactions to chemotherapy
- Protection Against Chemotherapy-Induced Alopecia
- Chemotherapy-induced alopecia
- p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- Predicting Quality of Life from Symptom Experience and Symptom Management Behaviors in Women with Ovarian Cancer Receiving Chemotherapy: A Cross-Sectional Study.
- Cutaneous complications of chemotherapeutic agents
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study